A Study of Hutchison MediPharma Limited(HMPL)-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms

Clinical trial NCT02857998 · COMPLETED

Trial details

NCT number: NCT02857998
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mature B-cell Neoplasms

Start date: 2016-12-27
Primary completion: 2021-06-30
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.